References
- Azhary H, Farooq MU, Bhanushali M, Majid A, Kassab MY. Peripheral neuropathy: Differential diagnosis and management. American Family Physician. 2010;81(7):887-892.
- Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20. European Journal of Cancer. 2005;41(8):1135-1139. http://dx.doi.org/10.1016/j.ejca.2005.02.012
- Dunlap B, Paice JA. Chemotherapy-induced peripheral neuropathy: A need for standardization in measurement. The Journal of Supportive Oncology. 2006;4(8):398-399.
- Delforge M, Blade J, Dimopoulos MA, Facon T, Kropff M, Ludwig H, et al. Treatment-related peripheral neuropathy in multiple myeloma: The challenge continues. Lancet Oncology. 2010;11(11):1086-1095. http://dx.doi.org/10.1016/s1470-2045(10)70068-1
- Kautio AL, Haanpaa M, Kautiainen H, Kalso E, Saarto T. Burden of chemotherapy-induced neuropathy-a cross-sectional study. Supportive Care in Cancer. 2011;19(12):1991-1996. http://dx.doi.org/10.1007/s00520-010-1043-2
- Kiser DW, Greer TB, Wilmoth MC, Dmochowski J, Naumann RW. Peripheral neuropathy in patients with gynecologic cancer receiving chemotherapy: Patient reports and provider assessments. Oncology Nursing Forum. 2010;37(6):758-764. http://dx.doi.org/10.1188/10.onf.758-764
- Tofthagen C, McAllister RD, McMillan SC. Peripheral neuropathy in patients with colorectal cancer receiving oxaliplatin. Clinical Journal of Oncology Nursing. 2011;15(2):182-188. http://dx.doi.org/10.1188/11.cjon.182-188
- Visovsky C, Collins M, Abbott L, Aschenbrenner J, Hart C. Putting evidence into practice: Evidence-based interventions for chemotherapy-induced peripheral neuropathy. Clinical Journal of Oncology Nursing. 2007;11(6):901-913. http://dx.doi.org/10.1188/07.cjon.901-913
- Richardson PG, Briemberg H, Jagannath S, Wen PY, Barlogie B, Berenson J, et al. Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib. Journal of Clinical Oncology. 2006;24(19):3113-3120. http://dx.doi.org/10.1200/jco.2005.04.7779
- Griffith KA, Merkies IS, Hill EE, Cornblath DR. Measures of chemotherapy-induced peripheral neuropathy: A systematic review of psychometric properties. Journal of the Peripheral Nervous System. 2010;15(4):314-325. http://dx.doi.org/10.1111/j.1529-8027.2010.00292.x
- Postma TJ, Heimans JJ. Grading of chemotherapy-induced peripheral neuropathy. Annals of Oncology. 2000;11(5):509-513. https://doi.org/10.1023/A:1008345613594
- Wickham R. Chemotherapy-induced peripheral neuropathy: A review and implications for oncology nursing practice. Clinical Journal of Oncology Nursing. 2007;11(3):361-376. http://dx.doi.org/10.1188/07.cjon.361-376
- Cavaletti G, Cornblath DR, Merkies IS, Postma TJ, Rossi E, Frigeni B, et al. The chemotherapy-induced peripheral neuropathy outcome measures standardization study: From consensus to the first validity and reliability findings. Annals of Oncology. 2013;24(2):454-462. http://dx.doi.org/10.1093/annonc/mds329
- Barton DL, Wos EJ, Qin R, Mattar BI, Green NB, Lanier KS, et al. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Supportive Care in Cancer. 2011;19(6):833-841. http://dx.doi.org/10.1007/s00520-010-0911-0
- Kim HY, Kang JH, Song CE, Youn HJ. Chemotherapy-induced peripheral neuropathy and quality of life in breast cancer patients. Asian Oncology Nursing. 2013;13(4):222-230. http://dx.doi.org/10.5388/aon.2013.13.4.222
- Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry. Journal of Clinical Oncology. 2013;31(21):2699-2707. http://dx.doi.org/10.1200/jco.2013.49.1514
- Kim JH, Choi KS, Kim TW, Hong YS. Quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy. Journal of Korean Oncology Nursing. 2011;11(3):254-262. http://dx.doi.org/10.5388/jkon.2011.11.3.254
- Kwak MK, Kim EJ, Lee ER, Kwon IG, Hwang MS. Characteristics and quality of life in patients with chemotherapy-induced peripheral neuropathy. Journal of Korean Oncology Nursing. 2010;10(2):231-239. http://dx.doi.org/10.5388/jkon.2010.10.2.231
- Dewolf L, Koller M, Velikova G, Johnson C, Scott N, Bottomley A. EORTC quality of life group translation procedure. 3rd ed. Brussels, BE: EORTC Quality of Life Group; 2009.
- Tabachnick BG, Fidell LS. Using multivariate statistics. 3rd ed. New York, NY: Harper Collins Publishers; 1996.
- Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. The EORTC QLQ-C30 scoring manual. 3rd ed. Brussels, BE: EORTC Quality of Life Group; 2001.
- Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, et al. Validation of the Korean version of the EORTC QLQ-C30. Quality of Life Research. 2004;13(4):863-868. https://doi.org/10.1023/B:QURE.0000021692.81214.70
- Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute. 1993;85(5):365-376. https://doi.org/10.1093/jnci/85.5.365
- Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. American Journal of Clinical Oncology. 1982;5(6):649-655. https://doi.org/10.1097/00000421-198212000-00014
- Kim GS. Analysis structural equation modeling. Seoul: Hannarae Publishing Co.; 2007.
- Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York, NY: McGraw-Hill; 1994.
- Kim EJ. Accessing factor structure and construct validity of the successful aging inventory. Journal of Korean Academy of Nursing. 2013;43(4):568-578. http://dx.doi.org/10.4040/jkan.2013.43.4.568
- Park HA. Problems and issues in developing measurement scales in nursing. Journal of Nursing Query. 2005;14(1):46-72.
- Kim SH, Jo MW, Lee SI. Psychometric properties of the Korean short form-36 health survey version 2 for assessing the general population. Asian Nursing Research. 2013;7(2):61-66. https://doi.org/10.1016/j.anr.2013.03.001
- Lee EH, Moon S, Cho SY, Oh YT, Chun M, Kim SH, et al. Psychometric evaluation of a need scale for cancer patients undergoing follow-up care. Journal of Korean Academy of Nursing. 2010;40(4):551-560. http://dx.doi.org/10.4040/jkan.2010.40.4.551
Cited by
- Relationship between Chemotherapy-induced Peripheral Neuropathy and Quality of Life in Patients with Hematologic Malignancies vol.27, pp.3, 2014, https://doi.org/10.7475/kjan.2015.27.3.358
- Psychometric Properties of Turkish Version of the Dutch Objective Burden Inventory vol.9, pp.3, 2015, https://doi.org/10.1016/j.anr.2015.07.001
- Oxaliplatin-Induced Peripheral Neuropathy and Quality of Life in Patients with Digestive System Cancer vol.28, pp.3, 2014, https://doi.org/10.7475/kjan.2016.28.3.343
- 항암제 유발 말초신경병증 변증평가도구의 신뢰도 및 타당도 평가 vol.37, pp.4, 2016, https://doi.org/10.22246/jikm.2016.37.4.631
- 항암제 유발 말초신경병증환자와 유기산검사 마커와의 상관성 연구 vol.38, pp.1, 2014, https://doi.org/10.13048/jkm.17007
- A Prospective Study of Chronic Oxaliplatin-Induced Neuropathy in Patients with Colon Cancer: Long-Term Outcomes and Predictors of Severe Oxaliplatin-Induced Neuropathy vol.14, pp.1, 2018, https://doi.org/10.3988/jcn.2018.14.1.81
- The evaluation of changes in peripheral neuropathy and quality-of-life using low-frequency electrostimulation in patients treated with chemotherapy for breast cancer: a study protocol vol.19, pp.1, 2014, https://doi.org/10.1186/s13063-018-2874-2
- Rasch model-based testing of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Chemotherapy-Induced Peripheral Neuropathy (QLQ-CIPN20) using Alliance vol.27, pp.7, 2014, https://doi.org/10.1007/s00520-018-4553-y
- A Randomized, Placebo-Controlled Trial Evaluating Changes in Peripheral Neuropathy and Quality of Life by Using Low-Frequency Electrostimulation on Breast Cancer Patients Treated With Chemotherapy vol.19, pp.None, 2020, https://doi.org/10.1177/1534735420925519
- Efficacy and safety of intravenous administration of high-dose selenium for preventing chemotherapy-induced peripheral neuropathy in platinum-sensitive recurrent ovarian, fallopian or primary peritone vol.32, pp.5, 2021, https://doi.org/10.3802/jgo.2021.32.e73
- Psychometric evaluation of the Arabic Version the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for Chemotherapy-Induced Peripheral Neuropathy Questionnaire vol.28, pp.5, 2021, https://doi.org/10.1080/23279095.2019.1677232